Moriyama Miyu, Chen I-Yin, Kawaguchi Atsushi, Koshiba Takumi, Nagata Kyosuke, Takeyama Haruko, Hasegawa Hideki, Ichinohe Takeshi
Division of Viral Infection, Department of Infectious Disease Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Department of Life Science and Medical Bioscience, Waseda University, Shinjuku-ku, Tokyo, Japan.
J Virol. 2016 Mar 28;90(8):4105-4114. doi: 10.1128/JVI.00120-16. Print 2016 Apr.
Inflammasomes are cytosolic multimolecular protein complexes that stimulate the activation of caspase-1 and the release of mature forms of interleukin-1β (IL-1β) and IL-18. We previously demonstrated that the influenza A virus M2 protein stimulates IL-1β secretion following activation of the nucleotide-binding oligomerization domain (NOD)-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome. The nonstructural protein 1 (NS1) of influenza virus inhibits caspase-1 activation and IL-1β secretion. However, the precise mechanism by which NS1 inhibits IL-1β secretion remains unknown. Here, we showed that J774A.1 macrophages stably expressing the NS1 protein inhibited IL-1β secretion after infection with recombinant influenza virus lacking the NS1 gene. Coimmunoprecipitation assay revealed that the NS1 protein interacts with NLRP3. Importantly, the NS1 protein inhibited the NLRP3/ASC-induced single-speck formation required for full activation of inflammasomes. The NS1 protein of other influenza virus strains, including a recent pandemic strain, also inhibited inflammasome-mediated IL-1β secretion. The NS1 RNA-binding domain (basic residues 38 and 41) and TRIM25-binding domain (acidic residues 96 and 97) were required for suppression of NLRP3 inflammasome-mediated IL-1β secretion. These results shed light on a mechanism by which the NS1 protein of influenza virus suppresses NLRP3 inflammasome-mediated IL-1β secretion.
Innate immune sensing of influenza virus via pattern recognition receptors not only plays a key role in generating type I interferons but also triggers inflammatory responses. We previously demonstrated that the influenza A virus M2 protein activates the NLRP3 inflammasome, leading to the secretion of interleukin-1β (IL-1β) and IL-18 following the activation of caspase-1. Although the nonstructural protein 1 (NS1) of influenza virus inhibits IL-1β secretion, the precise mechanism by which it achieves this remains to be defined. Here, we demonstrate that the NS1 protein interacts with NLRP3 to suppress NLRP3 inflammasome activation. J774A.1 macrophages stably expressing the NS1 protein suppressed NLRP3-mediated IL-1β secretion. The NS1 RNA-binding domain (basic residues 38 and 41) and TRIM25-binding domain (acidic residues 96 and 97) are important for suppression of NLRP3 inflammasome-mediated IL-1β secretion. These results will facilitate the development of new anti-inflammatory drugs.
炎性小体是胞质多分子蛋白复合物,可刺激半胱天冬酶-1的激活以及白细胞介素-1β(IL-1β)和IL-18成熟形式的释放。我们先前证明,甲型流感病毒M2蛋白在核苷酸结合寡聚化结构域(NOD)样受体家族含吡啉结构域3(NLRP3)炎性小体激活后刺激IL-1β分泌。流感病毒的非结构蛋白1(NS1)抑制半胱天冬酶-1的激活和IL-1β分泌。然而,NS1抑制IL-1β分泌的确切机制仍不清楚。在此,我们表明稳定表达NS1蛋白的J774A.1巨噬细胞在感染缺乏NS1基因的重组流感病毒后抑制IL-1β分泌。免疫共沉淀分析显示NS1蛋白与NLRP3相互作用。重要的是,NS1蛋白抑制炎性小体完全激活所需的NLRP3/凋亡相关斑点样蛋白(ASC)诱导的单斑点形成。包括最近的大流行毒株在内的其他流感病毒株的NS1蛋白也抑制炎性小体介导的IL-1β分泌。NS1 RNA结合结构域(碱性残基38和41)和TRIM25结合结构域(酸性残基96和97)是抑制NLRP3炎性小体介导的IL-1β分泌所必需的。这些结果揭示了流感病毒NS1蛋白抑制NLRP3炎性小体介导的IL-1β分泌的机制。
通过模式识别受体对流感病毒的天然免疫感知不仅在产生I型干扰素中起关键作用,而且还触发炎症反应。我们先前证明,甲型流感病毒M2蛋白激活NLRP3炎性小体,导致在半胱天冬酶-1激活后白细胞介素-1β(IL-1β)和IL-18的分泌。尽管流感病毒的非结构蛋白1(NS1)抑制IL-1β分泌,但其实现此目的的确切机制仍有待确定。在此,我们证明NS1蛋白与NLRP3相互作用以抑制NLRP3炎性小体激活。稳定表达NS1蛋白的J774A.1巨噬细胞抑制NLRP3介导的IL-1β分泌。NS1 RNA结合结构域(碱性残基38和41)和TRIM25结合结构域(酸性残基96和97)对于抑制NLRP3炎性小体介导的IL-1β分泌很重要。这些结果将有助于开发新的抗炎药物。